TB-402 Completed Phase 2 Trials for Prophylaxis of Venous Thromboembolic Events Prevention

Indications	Status	Purpose	Phase
DBCOND0051971 (Prophylaxis of Venous Thromboembolic Events)	Completed	Prevention	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01344954	Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery	Rivaroxaban (DB06228) TB-402 (DB06050)